SCHEMBL96752

SCHEMBL96752

[O]CCOCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.64
NAAA Q02083 1/20 0.47
IDO1 P14902 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 3/20 0.45
AGXT P21549 1/20 0.44
LTA4H P09960 1/20 0.44
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 1/20 0.43
CA7 P43166 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8062638 0.96 TSHR (0.58) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL10316554 0.96 TSHR (0.58) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL5566634 0.89 TSHR (0.56) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL2067114 0.86 TSHR (0.58) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL1991359 0.85 TSHR (0.78) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL96048 0.85 TSHR (0.56) TSHRNAAASMN1; SMN2HTTALDH1A1
SCHEMBL9489789 0.84 TSHR (0.61) TSHRNAAAIDO1SMN1; SMN2HTT
SCHEMBL97794 0.83 L3MBTL1 (0.54) TSHRNAAASMN1; SMN2ALDH1A1TDP1
SCHEMBL96808 0.83 L3MBTL1 (0.54) TSHRNAAASMN1; SMN2ALDH1A1TDP1
SCHEMBL9329653 0.83 TSHR (0.54) TSHRNAAAIDO1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118239868-A Carbamate substituted styryl sulfone compound and preparation method and application thereof 华夏生生药业(北京)有限公司 2024-06-25 CN claimed
CN-107252429-B Novel anti-inflammatory agent 雷斯韦洛吉克斯公司 2023-06-16 CN claimed
EP-4001263-A1 CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF Huaxiashengsheng Pharmaceutical Beijing Co., Ltd. (CN) 2022-05-25 EP claimed
CN-114072380-A Carbamate substituted styryl sulfone compound and preparation method and application thereof 华夏生生药业(北京)有限公司 2022-02-18 CN claimed
US-10918640-B2 Azetidine derivatives VERNALIS (R&D) LTD. (GB) 2021-02-16 US claimed
US-10383871-B2 Azetidine derivatives VERNALIS (R&D) LTD. (GB) 2019-08-20 US claimed
EP-2421533-B1 NOVEL ANTI-INFLAMMATORY AGENTS RESVERLOGIX CORP (CA) 2018-10-17 EP claimed
US-20170326143-A1 NOVEL ANTI-INFLAMMATORY AGENTS HEPALINK (HONG KONG) LIMITED (HK) 2017-11-16 US claimed
CN-107252429-A New antiinflammatory 雷斯韦洛吉克斯公司 2017-10-17 CN claimed
US-20170196864-A1 Azetidine Derivatives VERNALIS DEVELOPMENT LIMITED (GB) 2017-07-13 US claimed
US-4891057-A Phenylpyrazolecarboxylic acid derivatives, their preparation, and their use as plant-growth regulators and safeners HOECHST AKTIENGESELLSCHAFT (DE) 1990-01-02 US claimed
EP-0331529-A2 Diphenyl ether derivatives, process for producing the same and insecticide and acaricide containing the same as active ingredient UBE INDUSTRIES, LTD. (JP) 1989-09-06 EP claimed
EP-0269806-A1 Phenylpyrazole carbonic acid derivatives, their preparation and use as plant growth regulators and antidotes HOECHST AKTIENGESELLSCHAFT (DE) 1988-06-08 EP claimed
US-4747868-A Growth-regulating, fungicidal, and herbicidal cyclohexylimidazole and cyclohexenylimidazole derivatives, compositions, and methods of use therefor HOECHST AKTIENGESELLSCHAFT (DE) 1988-05-31 US claimed
EP-0243918-A2 1-Phenyl-imidazole compounds, process for their preparation and their use as growth regulators HOECHST AKTIENGESELLSCHAFT (DE) 1987-11-04 EP claimed
EP-0219798-A1 1,2,5-Substituted imidazole compounds, method for their preparation and their use as growth regulators HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-29 EP claimed
EP-0199206-A2 Cyclohexyl- and cyclohexenylimidazole compounds, process for their preparation and their use as plant-protective agents HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-29 EP claimed
EP-0186977-A2 Renin-inhibitory dipeptides, their preparation and use SANKYO COMPANY LIMITED (JP) 1986-07-09 EP claimed
EP-0185961-A2 1-Phenyl-imidazole-5-carboxylic acid derivatives, process for their preparation and their use as growth regulators HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-02 EP claimed
US-4011320-A PESTICIDES, FUNGICIDES SYNTEX (U.S.A.) INC. (US) 1977-03-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10918640-B2 Azetidine derivatives FAAH2, FAAH, APEH TSHR 1911/4885NAAA 160/4885IDO1 55/4885
US-20170196864-A1 Azetidine Derivatives FAAH2, FAAH, APEH TSHR 1911/4885NAAA 160/4885IDO1 55/4885
US-10383871-B2 Azetidine derivatives FAAH2, FAAH, APEH TSHR 1911/4885NAAA 160/4885IDO1 55/4885
US-20170326143-A1 NOVEL ANTI-INFLAMMATORY AGENTS VCAM1, ICAM1, IL6 TSHR 4123/4885NAAA 3748/4885IDO1 712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.